Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences
  • Healthcare
Life Sciences

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences
Healthcare

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Webcast
Conducting Robust Feasibility Assessment to De-risk External Comparator Studies
calendar

November 9, 2023

Kalender
clock

11:00am - 12:00pm

GMT

Register

View all IQVIA events
View Now

The U.S. Food and Drug Administration (FDA) guidance on real-world evidence (RWE) underscores the need for early engagement with the Agency to discuss real-world data (RWD) sources and non-interventional study designs prior to regulatory submission.

Join us for this webinar when we will explore how a robust and multidisciplinary feasibility methodology can de-risk regulatory and scientific strategy for external comparator studies. We will discuss key considerations for conducting feasibility assessment for external comparators utilizing RWD for regulatory submission, and strengthen understanding of these concepts through illustrative case studies.

Key takeaways:

  • Unpack why feasibility assessments are needed when designing external comparators
  • Highlight the essential processes for conducting feasibility assessments effectively
  • Examine opportunities and challenges in conducting feasibility assessments, along with strategic recommendations for successful execution

 

Speakers:

Leanne Li, MPH, MBA
 Sr. Principal, Regulatory Science & Study Innovation, IQVIA

Mayank Raizada, MS
 Principal, Regulatory Science & Study Innovation, IQVIA

Julien Heidt, MS
 Sr. Consultant, Regulatory Science & Study Innovation, IQVIA

Dony Patel, PhD
 Director, Global Database Studies, IQVIA

Related solutions

Real World Evidence

Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.

Contact Us